Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia

Journal of Leukocyte Biology

Volumn 68, Issue 3, 2000, Pages 413-422

  Persidsky, Y ^a   Zheng, J ^a   Miller, D ^a   Gendelman, H E ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Astrocyte; Chemokine; Chemokine receptor; Endothelial cell; Microglia; Tight junction

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ASTROCYTE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; DEMENTIA; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROGLIA; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TIGHT JUNCTION; VIRUS INFECTION;

AIDS DEMENTIA COMPLEX; ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN; HIV-1; HUMANS; MICROGLIA; NEURONS; PHAGOCYTES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033637632     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Dementia in AIDS patients: Incidence and risk factors
2. The neuropathogenesis of the AIDS dementia complex
3. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
4. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system
5. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues
6. Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlation with dementia
7. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia
8. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage
9. Accumulation of beta-amyloid precursor protein in HIV encephalitis: Relationship with neuropsychological abnormalities
10. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders
11. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis
12. Expression of pro- and anti-apoptosis gene products in brain from paediatric patients with HIV-1 encephalitis
13. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome
14. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement
15. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon
16. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis
17. HIV coat protein gp120 induces soluble neurotoxins in culture medium
18. CD40L activation of mononuclear phagocytes: Regulation of HIV-1 replication and beta-chemokine production
19. The role of mononuclear phagocytes in neurodegenerative disorders: Lessons from multiple sclerosis, Alzheimer's disease and HIV-1 dementia
20. The neuropathogenesis of HIV-1-dementia
21. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia
22. HIV-1 Tat induces neuronal death via tumor necrosis factor alpha and activation of non-NMDA receptors by a NFκB-independent mechanism
23. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis
24. Dementia associated with the acquired immunodeficiency syndrome
25. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes
26. Platelet-activating factor: A candidate human immunodeficiency virus type-1 infection neurotoxin
27. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurological status
28. Study of receptor-mediated neurotoxins released by HIV-1 infected mononuclear phagocytes found in human brain
29. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
30. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
31. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic
32. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1alpha mediated by the chemokine receptor CXCR4
33. CXCR4 mediates neuronal dysfunction by HIV-1 infected macrophage secretory product: Importance for HIV-1 associated dementia
34. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia
35. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain
36. Vascular changes in the cerebral cortex in HIV-1 infection
37. Vascular changes in the cerebral cortex in HIV-1 infection: I. A morphometric investigation by light and electron microscopy
38. Alterations in blood-brain barrier glucose transport in SIV-infected macaques
39. Brain metabolism: A perspective from the blood-brain barrier
40. The cell biology of the blood-brain barrier
41. Astrocytes induce blood-brain barrier properties in endothelial cells
42. The susceptibility of cerebral endothelial cells to astrogial induction of blood-brain barrier enzymes depends on their proliferative state
43. Glial cells and neurons induce blood-brain barrier enzymes in cerebral endothelial cells
44. Immunobiology of the blood-brain barrier
45. Impairments of blood-brain barrier function in HIV-1-associated dementia
46. Acquired immunodeficiency syndrome: Correlation of radiologic and pathologic findings in the brain
47. Single-photon emission computed tomography in human immunodeficiency virus encephalopathy: A preliminary report
48. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia
49. Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients
50. Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: A correlation with blood-brain-barrier dysfunction
51. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis
52. Human immunodeficiency virus encephalitis in SCID mice
53. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers
54. Astrocyte-drived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier
55. Chemokines and receptors in HIV encephalitis
56. HIV-1 infection alters chemokine β peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes
57. Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1
58. Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia
59. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis
60. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain
61. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis
62. SCID mice with HIV-1 encephalitis develop behavioral abnormalities
63. Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: Association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes
64. Chemokines and chemokine recptors in CNS pathology
65. Chemokine and chemokine receptor expression in the central nervous system
66. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
67. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals
68. Identification of a major co-receptor for primary isolates of HIV-1
69. Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia
70. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
71. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for Human Immunodeficiency Virus type 1 dementia isolates
72. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane. G protein-coupled receptor
73. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
74. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5
75. Human immunodeficiency virus-1 infection requires pertussis toxin sensitive G-protein-coupled signalling and mediates cAMP downregulation
76. Chemokine receptors and HIV
77. Expression of chemokine receptors by subsets of neurons in the central nervous system
78. CXCR-4 (fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1) is expressed in the human brain in a variety of cell types, including microglia and neurons
79. Chemokine receptors and T cell chemotaxis
80. Chemokines - Chemotactic cytokines that mediate inflammation
81. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS
82. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4
83. Chemokine receptor utilization by human immundeficiency virus type 1 isolates that replicate in microglia
84. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: Implications for human immunodeficiency virus type 1-associated dementia
85. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
86. Apoptosis induced by infection of primary brain cultures with diverse Human Immunodeficiency Virus type 1 isolates: Evidence for a role of the envelope
87. Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia
88. Neocortical damage during HIV infection
89. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity
90. α-Chemokines and their receptors in the neuronal signaling: Relevance for HIV-1-associated dementia
91. Cloning of a novel putative G-protein-coupled receptor (NLR) which is expressed in neuronal and lymphatic tissue
92. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony- stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha
93. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis
94. Apoptosis induced by HIV-1 infection of the central nervous system
95. Identification of apoptotic neurons in post-mortem brain tissue with HIV-1 encephalitis and progressive encephalopathy
96. Evidence of apoptotic cell death in HIV encephalitis
97. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechansim involving caspase activation, calcium overload, and oxidative stress
98. Caspases: Killer proteases
99. Caspases: The executioners of apoptosis
100. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis